Bai Zhi Extract.

Angelica dahurica carries furanocoumarins such as imperatorin and byakangelicin that slow CYP3A4 and CYP1A2, and piperine inhibits CYP3A4 and intestinal P-glycoprotein. Stacked, they raise the exposure of anything else in the formula that clears by those routes more than either alone.

St John's wort induces CYP3A4 and P-glycoprotein while the furanocoumarins of bai zhi inhibit them, so the two pull the same clearance route in opposite directions and the net effect is unpredictable. Both also carry photosensitising constituents, hypericin and psoralens, which add on light-exposed skin.

Both are Apiaceae roots carrying psoralen-type furanocoumarins, so stacking them raises total furanocoumarin intake and the additive photosensitising load on skin. Their slowing of the same CYP enzymes also points the same way.

Furanocoumarins of the imperatorin and byakangelicin type inhibit intestinal CYP3A4, and quercetin inhibits the same enzyme along with several efflux transporters. Taken together the two push in the same direction on first-pass metabolism, so co-ingested compounds that depend on CYP3A4 can reach higher exposure than either alone would produce. This is a pharmacokinetic interaction to plan around, not a benefit.

Silymarin flavonolignans inhibit UGT-mediated glucuronidation and, less strongly, some CYP activity. Stacked with a furanocoumarin-rich root extract the combined effect is on clearance of whatever else is in the formula. Anyone combining them should assume altered exposure of co-administered actives rather than a neutral pairing.

Curcumin inhibits CYP3A4 and intestinal glucuronidation, the same routes furanocoumarins hit. Co-formulating the two raises the chance that a third ingredient in the same capsule reaches unexpectedly high blood levels. The interaction is on drug and nutrient handling, so it belongs in formulation planning.

Angelica dahurica root appears in classical multi-herb Chinese formulas alongside licorice, which is used in that tradition as a harmonising and taste-modifying component. The pairing is documented as practice, and the practice is what is established, not a measured effect. Licorice carries its own mineralocorticoid-type activity at higher intakes, which should be accounted for separately.

Gan cao is the traditional name used for the licorice component of the same classical formulas that carry bai zhi. Recording it separately reflects how formulas are actually written on labels. As with licorice, what is established is the combination practice rather than an outcome.

Ginger and bai zhi co-occur in traditional warming formulas, and ginger is also used as a carminative to soften the gastric effect of a bitter root decoction. The pairing rests on formulation custom. Ginger has its own platelet effects worth noting when other antiplatelet ingredients are present.

Modern products that use bai zhi for upper-airway comfort frequently pair it with volatile oils such as peppermint, whose menthol produces a cooling sensation through TRPM8 activation. That sensory mechanism is established; the combination itself has not been tested as a unit. Keep the claim at the level of sensation, not of any structural change.

Ascorbate is routinely added to botanical upper-airway blends that include this root, mainly for its established role in normal immune function and as a formulation antioxidant. The two have not been studied together. Nothing about the pairing changes what either does on its own.